Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia

Atherosclerosis

Volumn 187, Issue 2, 2006, Pages 393-400

  Slatter, Tania L ^a   Williams, Michael J A ^a   Frikke Schmidt, Ruth ^b   Tybjærg Hansen, Anne ^b   Morison, Ian M ^a   McCormick, Sally P A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Rigshospitalet   (Denmark)

Author keywords

ATP binding cassette A1; Coronary artery disease; Familial hypoalphalipoproteinemia; High density lipoprotein; Tangier disease

Indexed keywords

ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN; MUTANT PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PROTEIN DISORDER; FAMILIAL DISEASE; FAMILIAL HYPOALPHALIPOPROTEINEMIA; FEMALE; GENE FUNCTION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM; TANGIER DISEASE;

ADULT; AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; FAMILY HEALTH; FEMALE; GENETIC SCREENING; GENETIC TESTING; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; TANGIER DISEASE;

EID: 33745483521     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.09.019     Document Type: Article

References (21)

1. Assman G., von Eckardstein A., and Brewer B.H. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular basis of inherited disease. 7th ed. (1995), McGraw-Hill, New York 2053-2072
2. Fredrickson D.S., Altrocchi P.H., Avioli L.V., et al. Tangier disease. Combined clinical staff conference at the National Institutes of Health. Ann Int Med 55 (1961) 1016-1031
3. Brooks-Wilson A., Marcil M., Clee S.M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22 (1999) 336-345
4. Bodzioch M., Orso E., Klucken J., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22 (1999) 347-351
5. Rust S., Rosier M., Funke H., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22 (1999) 352-355
6. Marcil M., Brooks-Wilson A., Clee S.M., et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 354 (1999) 1341-1346
7. Marcil M., Yu L., Krimbou L., et al. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler Thromb Vasc Biol 19 (1999) 159-169
8. Oram J.F. Tangier disease and ABCA1. Biochim Biophys Acta 1529 (2000) 321-330
9. Brousseau M.E., Eberhart G.P., Dupuis J., et al. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 41 (2000) 1125-1135
10. Santamarina-Fojo S., Peterson K., Knapper C., et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA 97 (2000) 7987-7992
11. Cohen J.C., Kiss R.S., Pertsemlidis A., et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
12. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., et al. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114 (2004) 1343-1353
13. Zwarts K.Y., Clee S.M., Zwinderman A.H., et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61 (2002) 115-125
14. Lutucuta S., Ballantyne C.M., Elghannam H., et al. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88 (2001) 969-973
15. Probst M.C., Thumann H., Aslanidis C., et al. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis 175 (2004) 269-279
16. Kyriakou T., Hodgkinson C., Pontefract D.E., et al. Genotypic Effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 418-423
17. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
18. Oefner P.J., and Underhill P.A. DNA mutation detection using denaturing high-performance-liquid chromatography (DHPLC). In: Dracopoli N.C., Haines J.L., Korf B.R., et al. (Eds). Current protocols in human genetics (1999), John Wiley & Sons, New York 7.10.1-7.10.12
19. Tregouet D.A., Ricard S., Nicaud V., et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 24 (2004) 775-781
20. Singaraja R.R., Brunham L.R., Visscher H., et al. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23 (2003) 1322-1332
21. Roosbeek S., Caster H., Liu Q.Z., et al. Expression and activity of the nucleotide-binding domains of the human ABCA1 transporter. Protein Expr Purif 35 (2004) 102-110